Dedifferentiated chondrosarcoma of the lung: Report of a case

Surgery Today ◽  
2011 ◽  
Vol 41 (2) ◽  
pp. 251-254 ◽  
Author(s):  
Daigo Kawano ◽  
Ichiro Yoshino ◽  
Fumihiro Shoji ◽  
Kensaku Ito ◽  
Tokujiro Yano ◽  
...  
Keyword(s):  
Dedifferentiated Chondrosarcoma

Chromosomal changes in a dedifferentiated chondrosarcoma

2001 ◽  
Vol 124 (2) ◽  
pp. 105-111 ◽  
Author(s):  
Dennis P O'Malley ◽  
Kent E Opheim ◽  
Todd S Barry ◽  
Douglas B Chapman ◽  
Mary J Emond ◽  
...  
Keyword(s):  
Dedifferentiated Chondrosarcoma ◽  
Chromosomal Changes

Dedifferentiated chondrosarcoma: A report of the clinicopathologic features and outcomes of 16 cases treated at a single institution.

2021 ◽  
Vol 39 (15_suppl) ◽  
pp. e23500-e23500
Author(s):  
Charles Gusho ◽  
Steven Gitelis ◽  
Alan T. Blank
Keyword(s):  
Poor Prognosis ◽  
Nonoperative Management ◽  
Clinicopathological Features ◽  
Clinicopathologic Features ◽  
Single Institution ◽  
Dedifferentiated Chondrosarcoma ◽  
Wide Margin ◽  
The Poor ◽  
Kaplan Meier ◽  
Period Data

e23500 Background: Dedifferentiated chondrosarcoma (DCS) is a rare and aggressive malignancy with a poor prognosis. The purpose of this investigation was to assess the clinicopathological features and outcomes of DCS patients treated at a single institution. Methods: This study was a retrospective review over a consecutive twenty-year period. Data including treatment details and outcomes were recorded. Results: A total of 16 cases from 2000 to 2018 were reviewed. The median age was 62 years (IQR, 52-69 years) and the majority of DCS arose in the femur (50%, n = 8) and pelvis (25%, n = 4). Fourteen (88%) cases received limb salvage/wide margin resection (n = 13) or intralesional surgery (n = 1). For all DCS, the median estimated overall survival (OS) was 46 months (95% CI, 1-90 months) with both a five and ten-year survival probability of 32%. On Kaplan-Meier analysis there was no difference between operative versus nonoperative management (p = 0.747), surgery alone versus surgery/chemotherapy (p = 0.265), nor surgery alone versus surgery/chemotherapy/radiation (p = 0.698). Conclusions: Our findings confirm the poor prognosis of DCS patients, though with a five-year estimate of 32%, higher than previous literature. Together with existing literature, our data may enable future strategic recommendation of DCS patients.

scholarly journals Dedifferentiated chondrosarcoma of the maxilla

2007 ◽  
Vol 3 (1) ◽  
pp. 53 ◽  
Author(s):  
Anusheel Munshi ◽  
SurinderKumar Atri ◽  
KailashChander Pandey ◽  
MC Sharma
Keyword(s):  
Dedifferentiated Chondrosarcoma

Dedifferentiated chondrosarcoma: radiographic features.

Radiology ◽  
1986 ◽  
Vol 161 (2) ◽  
pp. 489-492 ◽  
Author(s):  
E E de Lange ◽  
T L Pope ◽  
R E Fechner
Keyword(s):  
Dedifferentiated Chondrosarcoma ◽  
Radiographic Features

Dedifferentiated chondrosarcoma.

1988 ◽  
Vol 70 (1) ◽  
pp. 60-69 ◽  
Author(s):  
R Capanna ◽  
F Bertoni ◽  
G Bettelli ◽  
P Picci ◽  
P Bacchini ◽  
...  
Keyword(s):  
Dedifferentiated Chondrosarcoma

Dedifferentiated Chondrosarcoma: The Role of Chemotherapy with Updated Outcomes

2004 ◽  
Vol 86 (11) ◽  
pp. 2412-2418 ◽  
Author(s):  
Ian D. Dickey ◽  
Peter S. Rose ◽  
Bruno Fuchs ◽  
Lester E. Wold ◽  
Scott H. Okuno ◽  
...  
Keyword(s):  
Dedifferentiated Chondrosarcoma
Sign in / Sign up

Export Citation Format

Share Document